Skip to main content
Equibles

BETA · Beta Drugs Limited

Use BETA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BETA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1,817.40 INR -21.10 (-1.15%) At close · Nov 13
Rebalance outlook locked
Market Cap
20.21B INR
Shares
11.12M
Volume · Nov 13 11.61K Avg daily vol (3M) 40.37K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close1,817.40 INR Open1,874.90 INR Day1,810.50–1,890.70 INR 52W close1,030.30–2,668.30 INR Avg vol 30d62K Last earningsOct 22, 2026 DataMar 2025–Nov 2026

Raw chart and full-history price indicators begin at the captured split on Mar 26, 2025; bars on opposite sides are not compared.

Latest documents

2026
Oct 22
Earnings call
Q2 2027 earnings call

Beta Drugs reported H1 FY27 revenue growth of 29.2%, EBITDA margin of 23.18% and PAT growth of almost 45% to INR34 crores. Management targets 20%, 25% growth, FY27 own-brand sales of INR150 crores and said trade margin capping has negligible impact.

All documents

Quarterly results

Revenue Net income Net loss
· 872.67M INR 0 INR '26 Q3 · 939.65M INR 90.49M INR '26 Q4 · 1.26B INR 0 INR '27 Q1 LATEST · 1.37B INR 0 INR '27 Q2

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 1,030.30 INR Now 1,817.40 INR · 48% Range high 2,668.30 INR
vs 200-day avg +5% vs 50-day avg -7%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

Raw-price comparisons begin at the captured split on Mar 26, 2025; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
XNSE:BETA +0.6% +3.8% +32.0% +1.1% +17.3%

Exchange listing

Market
XNSE
Ticker
BETA
ISIN
INE351Y01019
Security
Ordinary share
Trading currency
INR

Company

Website
https://betadrugslimited.com/
Investor relations
https://www.betadrugslimited.com/investor-contacts/

Other listings of this company

No other verified listings are available.

Recent dividends

No verified dividend payments are available for this listing yet.

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-10-22 Audio Transcript
    Earnings Call
  • Earnings call · Q4 2026 2026-05-15 Audio Transcript
    Earnings Call